IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Seelos Therapeutics Inc

CUSIP: 81577F109 | 246 institutional holders

Quarters

Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2023

LM Advisors LLC83
0.0% of portfolio›$115
StyleTurnoverLocationFiled
LM Advisors LLC
83$1150.0%ETFHighSan Diego, CA2024-02-14